These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 13088945)
21. [Clinical experiences with the anticoagulant sintrom]. NANNINGA HS Ned Tijdschr Geneeskd; 1956 Nov; 100(46):3343-4. PubMed ID: 13387887 [No Abstract] [Full Text] [Related]
22. Clinical evaluation of a new oral anticoagulant sintrom. NEILL EC; MOON RY; VANDER VEER JB Circulation; 1957 May; 15(5):713-20. PubMed ID: 13427125 [No Abstract] [Full Text] [Related]
23. [Results of specific treatment of thromboembolism with anticoagulants cumid and athrombon]. RASSLER R Z Geburtshilfe Gynakol; 1955; 144(1):92-104. PubMed ID: 13300252 [No Abstract] [Full Text] [Related]
24. Clinical experiences with heparin and warfarin sodium: report of 150 cases. SETNAR MI J Am Osteopath Assoc; 1962 Sep; 62():41-52. PubMed ID: 13910968 [No Abstract] [Full Text] [Related]
25. Clinical experiences with warfarin (coumadin) sodium as an anticoagulant. BAER S; YARROW MW; KRAVITZ C; MARKSON V J Am Med Assoc; 1958 Jun; 167(6):704-8. PubMed ID: 13538752 [No Abstract] [Full Text] [Related]
26. Laboratory control of anticoagulant treatment with coumarin derivatives. GONYEA LM; BRIDGES RA Univ Minn Med Bull; 1962 Jan; 33():164-80. PubMed ID: 13900168 [No Abstract] [Full Text] [Related]
27. [A new synthetic anticoagulant: warfarin]. RAVINA A Presse Med (1893); 1956 Mar; 64(19):433. PubMed ID: 13335800 [No Abstract] [Full Text] [Related]
28. Bronchodilator action of the anticoagulant warfarin sodium. BLUMBERG H; DAYTON HB; GORDON SM Science; 1958 Jan; 127(3291):188. PubMed ID: 13495497 [No Abstract] [Full Text] [Related]
30. A comparative evaluation of tromexan and dicumarol in the treatment of thromboembolic conditions--based on experience with 514 patients; a report of the Committee on Anticoagulants of the American Heart Association. SCARRONE LA; BECK DF; WRIGHT IS Circulation; 1952 Oct; 6(4):489-514. PubMed ID: 12979062 [No Abstract] [Full Text] [Related]
36. Clinical experiences with the anticoagulant warfarin sodium (coumadin sodium). PORTER RR; RICHARDSON D; MAUCK HP Va Med Mon (1918); 1958 Sep; 85(9):465-71. PubMed ID: 13581501 [No Abstract] [Full Text] [Related]
37. [Clinical results with the anticoagulant sintrom (G 23350)]. OBE G Ther Ggw; 1956 Jan; 95(1):17-9. PubMed ID: 13299281 [No Abstract] [Full Text] [Related]
38. [Anticoagulant properties and therapeutic use of a new coumarin derivative: 3-[2-acetyl-1-(p-nitrophenol)-ethyl]-4-hydroxycoumarin or coumarin G 23350]. LEROUX M; JAMAIN B Therapie; 1956; 11(1):85-101. PubMed ID: 13337762 [No Abstract] [Full Text] [Related]
39. Synthesis of 3-amino-4-hydroxy coumarin and dihydroxy-phenyl coumarins as novel anticoagulants. Danis O; Yuce-Dursun B; Gunduz C; Ogan A; Sener G; Bulut M; Yarat A Arzneimittelforschung; 2010; 60(10):617-20. PubMed ID: 21125812 [TBL] [Abstract][Full Text] [Related]
40. Anticoagulant studies with marcoumar, a new coumarin derivative. PRIOR IA Br Med J; 1955 Oct; 2(4945):944-6. PubMed ID: 13260634 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]